financetom
Business
financetom
/
Business
/
P10 Outperformed Expectations in Q2 With Strong Fees, Shares Undervalued, Oppenheimer Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
P10 Outperformed Expectations in Q2 With Strong Fees, Shares Undervalued, Oppenheimer Says
Aug 12, 2024 8:09 AM

10:56 AM EDT, 08/12/2024 (MT Newswires) -- P10's (PX) Q2 adjusted earnings exceeded estimates due to "stronger than expected catch-up management fees of $6 million," Oppenheimer said in a note on Monday.

The firm said unexpected gains in incentive fees also contributed to the revenue in the "other" category.

Oppenheimer said it will keep estimates relatively unchanged as P10's "assets under management, fee rates excluding catch-up and core expenses were all close to expectations."

The company's shares are "significantly undervalued" and there is an upside for P10 in the long term as the company settles into "the new normal" following the appointment of the current CEO Luke Sarsfield in October 2023, the firm added.

Oppenheimer reiterated its outperform rating on P10's stock and kept the price target at $13.

Price: 9.57, Change: +0.27, Percent Change: +2.90

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hims & Hers Health Insider Sold Shares Worth $506,061, According to a Recent SEC Filing
Hims & Hers Health Insider Sold Shares Worth $506,061, According to a Recent SEC Filing
Sep 21, 2025
04:34 PM EDT, 09/19/2025 (MT Newswires) -- Patrick Harrison Carroll, Director, Chief Medical Officer, on September 17, 2025, sold 10,021 shares in Hims & Hers Health ( HIMS ) for $506,061. Following the Form 4 filing with the SEC, Carroll has control over a total of 169,940 Class A common shares of the company, with 169,940 shares held directly. SEC...
Hims & Hers Health Insider Sold Shares Worth $3,292,906, According to a Recent SEC Filing
Hims & Hers Health Insider Sold Shares Worth $3,292,906, According to a Recent SEC Filing
Sep 21, 2025
04:35 PM EDT, 09/19/2025 (MT Newswires) -- Andrew Dudum, 10% Owner, Director, Chief Executive Officer, on September 17, 2025, sold 65,110 shares in Hims & Hers Health ( HIMS ) for $3,292,906. Following the Form 4 filing with the SEC, Dudum has control over a total of 95,315 Class A common shares of the company, with 95,315 shares held directly....
Hims & Hers Health Insider Sold Shares Worth $694,325, According to a Recent SEC Filing
Hims & Hers Health Insider Sold Shares Worth $694,325, According to a Recent SEC Filing
Sep 21, 2025
04:35 PM EDT, 09/19/2025 (MT Newswires) -- Michael Chi, Chief Commercial Officer, on September 17, 2025, sold 13,749 shares in Hims & Hers Health ( HIMS ) for $694,325. Following the Form 4 filing with the SEC, Chi has control over a total of 297,139 Class A common shares of the company, with 297,139 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1773751/000177375125000312/xslF345X05/wk-form4_1758313675.xml...
Southside Bancshares CEO Lee Gibson to Retire
Southside Bancshares CEO Lee Gibson to Retire
Sep 21, 2025
04:36 PM EDT, 09/19/2025 (MT Newswires) -- Southside Bancshares ( SBSI ) said late Friday that Chief Executive Officer Lee Gibson will retire, effective Dec. 31. Gibson will continue as a director of the company and Southside Bank. Keith Donahoe, president of the company and the bank, will succeed him as CEO, according to a statement. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved